Rapid ATP-Bioluminescence for Non-sterile Product Testing: Roadmap to Implementation Webinar Overview Despite the clear advantages rapid microbiological methods (RMMs) provide over traditional ones, the pharmaceutical
Scientific Poster: Demonstrating Equivalency and Limit of Detection for a Rapid Sterility Method using ATP-Bioluminescence
Technical Report: Determining Proof of Concept of an Alternative Sterility Test Using Celsis AMPiScreen® Amplified ATP Bioluminescence on a Broad Range of Pharmaceutical Products Determining
What is Your Microbial ID Program Really Costing You? Take this five-question survey to start your cost analysis. START
Optimizing MALDI-TOF for Filamentous Fungi Identification Webinar Overview Recovering fungal samples from environmental monitoring (EM) is a concern for all pharmaceutical, medical device, and consumer
Filamentous Fungi – Facilities Facing Facts Real risks affecting real people. Ziva Abraham discusses the reality and importance of preventing mold contamination Ziva Abraham is
Safety Doesn’t Stop After Approval How microbial testing keeps vaccines safe Vaccine development typically takes years, even decades. How then could companies deliver COVID-19 vaccines
Pharma in 2021 and Beyond: 7 Trends That Will Drive the Industry Survey analyzed more than 1,000 responses concerning microbiological methods The biopharmaceutical industry is
Product & Service Providers in: COMPOUNDING ENVIRONMENTAL MONITORING QUALITY CONTROL/TESTING As Seen In: View Charles River Case Study:
How Does USP Chapter <797> Impact Your Microbial Identification? Join us for an in-depth look at the current and future requirements of microbial identification as